141 related articles for article (PubMed ID: 8017866)
21. Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls.
Sun JB; Olsson T; Wang WZ; Xiao BG; Kostulas V; Fredrikson S; Ekre HP; Link H
Eur J Immunol; 1991 Jun; 21(6):1461-8. PubMed ID: 1710567
[TBL] [Abstract][Full Text] [Related]
22. Cerebrospinal fluid anti-myelin antibodies are related to magnetic resonance measures of disease activity in multiple sclerosis.
Vogt MH; Teunissen CE; Iacobaeus E; Heijnen DA; Breij EC; Olsson T; Brundin L; Killestein J; Dijkstra CD
J Neurol Neurosurg Psychiatry; 2009 Oct; 80(10):1110-5. PubMed ID: 18931010
[TBL] [Abstract][Full Text] [Related]
23. Studies on anti-myelin antibodies in patients with multiple sclerosis.
Nobile-Orazio E; Spagnol G; Daverio R; Riboni L; Macchi R; Francomano E; Scarlato G
Riv Neurol; 1987; 57(1):13-9. PubMed ID: 3629125
[TBL] [Abstract][Full Text] [Related]
24. Elevated levels of antibody to myelin oligodendrocyte glycoprotein is not specific for patients with multiple sclerosis.
Karni A; Bakimer-Kleiner R; Abramsky O; Ben-Nun A
Arch Neurol; 1999 Mar; 56(3):311-5. PubMed ID: 10190821
[TBL] [Abstract][Full Text] [Related]
25. Antigen-specific TGF-beta1 secretion with bovine myelin oral tolerization in multiple sclerosis.
Fukaura H; Kent SC; Pietrusewicz MJ; Khoury SJ; Weiner HL; Hafler DA
Ann N Y Acad Sci; 1996 Feb; 778():251-7. PubMed ID: 8610978
[TBL] [Abstract][Full Text] [Related]
26. Antimyelin basic protein and antimyelin antibody-producing cells in multiple sclerosis.
Olsson T; Baig S; Höjeberg B; Link H
Ann Neurol; 1990 Feb; 27(2):132-6. PubMed ID: 1690527
[TBL] [Abstract][Full Text] [Related]
27. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients.
Fukaura H; Kent SC; Pietrusewicz MJ; Khoury SJ; Weiner HL; Hafler DA
J Clin Invest; 1996 Jul; 98(1):70-7. PubMed ID: 8690806
[TBL] [Abstract][Full Text] [Related]
28. Immunotherapy for multiple sclerosis: basic insights for new clinical strategies.
Mouzaki A; Tselios T; Papathanassopoulos P; Matsoukas I; Chatzantoni K
Curr Neurovasc Res; 2004 Oct; 1(4):325-40. PubMed ID: 16181082
[TBL] [Abstract][Full Text] [Related]
29. Epitope specificity and V gene expression of cerebrospinal fluid T cells specific for intact versus cryptic epitopes of myelin basic protein.
Satyanarayana K; Chou YK; Bourdette D; Whitham R; Hashim GA; Offner H; Vandenbark AA
J Neuroimmunol; 1993 Apr; 44(1):57-67. PubMed ID: 7684400
[TBL] [Abstract][Full Text] [Related]
30. Presentation of alpha B-crystallin to T cells in active multiple sclerosis lesions: an early event following inflammatory demyelination.
Bajramović JJ; Plomp AC; Goes Av; Koevoets C; Newcombe J; Cuzner ML; van Noort JM
J Immunol; 2000 Apr; 164(8):4359-66. PubMed ID: 10754336
[TBL] [Abstract][Full Text] [Related]
31. Multiple sclerosis: cells secreting antibodies against myelin-associated glycoprotein are present in cerebrospinal fluid.
Baig S; Olsson T; Yu-Ping J; Höjeberg B; Cruz M; Link H
Scand J Immunol; 1991 Jan; 33(1):73-9. PubMed ID: 1705050
[TBL] [Abstract][Full Text] [Related]
32. Intrathecal CD4(+) and CD8(+) T-cell responses to endogenously synthesized candidate disease-associated human autoantigens in multiple sclerosis patients.
van Nierop GP; Janssen M; Mitterreiter JG; van de Vijver DA; de Swart RL; Haagmans BL; Verjans GM; Hintzen RQ
Eur J Immunol; 2016 Feb; 46(2):347-53. PubMed ID: 26507805
[TBL] [Abstract][Full Text] [Related]
33. Cells producing antibodies specific for myelin basic protein region 70-89 are predominant in cerebrospinal fluid from patients with multiple sclerosis.
Martino G; Olsson T; Fredrikson S; Hojeberg B; Kostulas V; Grimaldi LM; Link H
Eur J Immunol; 1991 Dec; 21(12):2971-6. PubMed ID: 1721023
[TBL] [Abstract][Full Text] [Related]
34. CSF T-cell subsets in multiple sclerosis: relationship to cerebrospinal fluid myelin basic protein and clinical activity.
Salmaggi A; LaMantia L; Milanese C; Bianchi G; Eoli M; Campi A; Nespolo A
J Neurol; 1989 Sep; 236(6):336-9. PubMed ID: 2477508
[TBL] [Abstract][Full Text] [Related]
35. T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis.
Sun J; Link H; Olsson T; Xiao BG; Andersson G; Ekre HP; Linington C; Diener P
J Immunol; 1991 Mar; 146(5):1490-5. PubMed ID: 1899688
[TBL] [Abstract][Full Text] [Related]
36. Anti-MOG autoantibodies in Italian multiple sclerosis patients: specificity, sensitivity and clinical association.
Mantegazza R; Cristaldini P; Bernasconi P; Baggi F; Pedotti R; Piccini I; Mascoli N; La Mantia L; Antozzi C; Simoncini O; Cornelio F; Milanese C
Int Immunol; 2004 Apr; 16(4):559-65. PubMed ID: 15039386
[TBL] [Abstract][Full Text] [Related]
37. Immunological mechanisms that associate with oligoclonal IgM band synthesis in multiple sclerosis.
Villar LM; Espiño M; Cavanillas ML; Roldán E; Urcelay E; de la Concha EG; Sádaba MC; Arroyo R; González-Porqué P; Alvarez-Cermeño JC
Clin Immunol; 2010 Oct; 137(1):51-9. PubMed ID: 20621566
[TBL] [Abstract][Full Text] [Related]
38. Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
Horellou P; Wang M; Keo V; Chrétien P; Serguera C; Waters P; Deiva K
J Neuroimmunol; 2015 Dec; 289():1-7. PubMed ID: 26616865
[TBL] [Abstract][Full Text] [Related]
39. Autoreactive T lymphocytes in multiple sclerosis: pathogenic role and therapeutic targeting.
Stinissen P; Raus J
Acta Neurol Belg; 1999 Mar; 99(1):65-9. PubMed ID: 10218096
[TBL] [Abstract][Full Text] [Related]
40. T cells from multiple sclerosis patients recognize immunoglobulin G from cerebrospinal fluid.
Holmøy T; Vandvik B; Vartdal F
Mult Scler; 2003 Jun; 9(3):228-34. PubMed ID: 12814167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
